Biochemical, Hematological and Clinical Profile of Dengue Patients in a Tertiary Care Centre
DOI:
https://doi.org/10.47489/szmc.v39i2.703Keywords:
Platelets, Hemoglobin, Hematocrit, Classic dengue, Dengue Hemrrhagic feverAbstract
Background: Dengue is an arboviral infection caused by four dengue virus serotypes (DENV 1–4), with a global incidence that disproportionately affects tropical and subtropical regions. Despite a significant disease burden in Pakistan, local data on the hematological and biochemical profiles of different dengue categories is limited and not generating reliable evidence for clinical decision making.
Objective: To evaluate differences in clinical features, hematological indices, and biochemical parameters across classic dengue (CD), dengue hemorrhagic fever (DHF), and severe dengue (SD) and to corelate findings with severity of disease.
Method: A cross-sectional study design was conducted from Nov. 2021 to Nov. 2022, at three tertiary care military hospitals in Pakistan. 131 inpatients aged 14 years or older with confirmed dengue infection via NS1 antigen or serology, who presented within 72 hours of fever onset were eligible and included in the study. Systemic diseases and concurrent infections were excluded. Data were collected using a standardized tool capturing clinical features and laboratory parameters (hemoglobin, hematocrit, platelet count, total leukocyte count). Data were analyzed with SPSS v24.0, employing descriptive statistics and inferential tests (chi-square, one-way ANOVA) at a 95% confidence level.
Results: Of the 131 patients (62% male, 38% female), the highest frequency seen in the 15–30-year age group. Platelet count emerged as a significant marker of severity, with SD cases showing the lowest mean platelet counts (p<0.001). Leukopenia was observed in 84% of cases, though hemoglobin and hematocrit largely remained within normal limits across all dengue categories. DHF cases demonstrated the highest frequency of bleeding manifestations (10%). No mortality was recorded in the study population.
Conclusion: The study elucidated distinct hematological, clinical and biochemical profiles across dengue categories. The platelet count proved to be a reliable, low-cost marker for early severity grading, complemented by the consistent presence of leukopenia. These findings provide local data to refine triage and management protocols, addressing a significant gap in the diagnostic approach to dengue in Pakistan’s resource-constrained healthcare settings.
References
Harapan, H., Michie, A., Sasmono, R. T., & Imrie, A. (2020). Dengue: A minireview. Viruses, 12(8), 829. http://doi.org/10.3390/v12080829
Chala, B., & Hamde, F. (2021). Emerging and re-emerging vector-borne infectious diseases and the challenges for control: A review. Frontiers in Public Health, 9. https://doi.org/10.3389/fpubh.2021.715759
Kularatne, S. A., & Dalugama, C. (2022). Dengue infection: Global importance, immunopathology and management. Clinical Medicine (London, England), 22(1), 9–13. http://doi.org/10.7861/clinmed.2021-0678
Dengue and severe dengue. (n.d.). Who.int. Retrieved March 21, 2024, from https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-denguehttps://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue
Sunil, S., N. Sirisena, P. D. N., Mahilkar, S., Sharma, C., & Jain, J. (2021). Concurrent dengue infections: Epidemiology & clinical implications. The Indian Journal of Medical Research, 154(5), 669. https://doi.org/10.4103/ijmr.ijmr_1219_18
Kok, B. H., Lim, H. T., Lim, C. P., Lai, N. S., Leow, C. Y., & Leow, C. H. (2023). Dengue virus infection – a review of pathogenesis, vaccines, diagnosis and therapy. Virus Research, 324(199018), 199018. http://doi.org/10.1016/j.virusres.2022.199018
Raafat, N., Blacksell, S. D., & Maude, R. J. (2019). A review of dengue diagnostics and implications for surveillance and control. Transactions of the Royal Society of Tropical Medicine and Hygiene, 113(11), 653–660. https://doi.org/10.1093/trstmh/trz068
Fongwen, N., Wilder-Smith, A., Gubler, D. J., Ooi, E. E., T. Salvana, E. M., de Lamballerie, X., Olliaro, P. L., & Peeling, R. W. (2021). Target product profile for a dengue pre-vaccination screening test. PLoS Neglected Tropical Diseases, 15(7), e0009557. http://doi.org/10.1371/journal.pntd.0009557
Wang, W.-H., Urbina, A. N., Chang, M. R., Assavalapsakul, W., Lu, P.-L., Chen, Y.-H., & Wang, S.-F. (2020). Dengue hemorrhagic fever – A systemic literature review of current perspectives on pathogenesis, prevention and control. Wei Mian Yu Gan Ran Za Zhi [Journal of Microbiology, Immunology, and Infection], 53(6), 963–978. https://doi.org/10.1016/j.jmii.2020.03.007
Mutanabbi, M., Shova, S. S., Kibtiar, M., & Mosleh, T. (2022). Clinical profile and lab findings of dengue fever in children admitted in a tertiary care hospital. Mymensingh Medical Journal: MMJ, 31(3), 741–748.https://pubmed.ncbi.nlm.nih.gov/35780359/
Vijay, J., Anuradha, N., & Anbalagan, V. P. (2022). Clinical presentation and platelet profile of dengue fever: A retrospective study. Cureus. https://doi.org/10.7759/cureus.28626
Ananda Rao, A., R, R., Gosavi, S., & Menon, S. (2020). Dengue fever: Prognostic insights from a complete blood count. Cureus. https://doi.org/10.7759/cureus.11594
Macias, A. E., Werneck, G. L., Castro, R., Mascareñas, C., Coudeville, L., Morley, D., Recamier, V., Guergova-Kuras, M., Etcheto, A., Puentes-Rosas, E., Baurin, N., & Toh, M.-L. (2021). Mortality among hospitalized dengue patients with comorbidities in Mexico, Brazil, and Colombia. The American Journal of Tropical Medicine and Hygiene. https://doi.org/10.4269/ajtmh.20-1163
Verma, R., Kumar, M., & Mishra, B. (2020). Prevalence of dengue fever in Western Uttar Pradesh, India: A gender-based study. InternSational Journal of Applied & Basic Medical Research, 10(1), 8. https://doi.org/10.4103/ijabmr.IJABMR_337_18
Yang, J., Mosabbir, A. A., Raheem, E., Hu, W., & Hossain, M. S. (2023). Demographic characteristics, clinical symptoms, biochemical markers and probability of occurrence of severe dengue: A multicenter hospital-based study in Bangladesh. PLoS Neglected Tropical Diseases, 17(3), e0011161. https://doi.org/10.1371/journal.pntd.0011161
Haider, N. (2023). Bangladesh’s 2023 Dengue outbreak-age/gender-related disparity in morbidity and mortality and geographic variability of epidemic burdens. International Journal of Infectious Diseases, 136, 1–4. https://doi.org/10.1016/j.ijid.2023.08.026
Triana, D., Kurniati, A., & Wirastari, G. G. (2020). Relationship Between Platelet, Hematocrit and Leukocyte with Dengue Severity in (Vol. 7). https://www.researchgate.net/publication/348694543_European_Journal_of_Molecular_Clinical_Medicine
Riswari, S. F., Budiman, M. F., Darmayanti, D., Ernawati, Prodjosoewojo, S., Susandi, E., Oehadian, A., & Alisjahbana, B. (2022). A comparison of the accuracy of handheld hemoglobinometer and hematocrit measurements for detecting plasma leakage in dengue hemorrhagic fever. International Journal of General Medicine, 15, 2589–2595. https://doi.org/10.2147/ijgm.s343017
Malik, J. (2023). Association of pattern of thrombocytopenia and serology with timings of plasma leakage in patients of dengue hemorrhagic fever during dengue epidemic 2019-an experience from Rawalpindi Medical University: A cross sectional study. The Professional Medical Journal, 30, 461–466. https://doi.org/10.29309/TPMJ/2023.30.04.7362
Yasuda, I., Saito, N., Suzuki, M., Umipig, D. V., Solante, R. M., Guzman, F. D., Sayo, A. R., Yasunami, M., Koizumi, N., Kitashoji, E., Sakashita, K., Ng, C. F. S., Smith, C., & Ariyoshi, K. (2021). Unique characteristics of new complete blood count parameters, the Immature Platelet Fraction and the Immature Platelet Fraction Count, in dengue patients. PloS One, 16(11), e0258936. http://doi.org/10.1371/journal.pone.0258936
Meena, V., Kumar, S., & Bihari, S. R. (2020). Diagnostic significance of platelet indices in dengue fever in endemic area. Int J Res Rev, 7(2), 315–319. https://www.ijrrjournal.com/IJRR_Vol.7_Issue.2_Feb2020/IJRR0050.pdf
Ahmad, W., Lubna, Z., Mohsin, A., & Nishat, A. (2020). Study of platelet indices in dengue fever with thrombocytopenia and correlation of immature platelet fraction (IPF) with platelet recovery. Archives of Hematology Case Reports and Reviews, 5(1), 001–005. https://www.clinsurggroup.us/articles/AHCRR-5-121.php
Islam MM, Sultana A, Banu S, et al. Clinical and laboratory profile of classic dengue, dengue hemorrhagic fever, and severe dengue in Bangladesh: A cross-sectional study. PLoS Negl Trop Dis. 2022;16(9):e0010879. doi:10.1371/journal.pntd.0010879. PMID: 36107647; PMCID: PMC10582778. https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0010847
This work is licensed under a 